Style | Citing Format |
---|---|
MLA | Azimi T, et al.. "The Possible Role of Pathogenic and Non-Pathogenic Bacteria in Initiation and Exacerbation of Celiac Disease; a Comprehensive Review." Current Pharmaceutical Biotechnology, vol. 21, no. 6, 2020, pp. 452-466. |
APA | Azimi T, Nasser A, Shariati A, Shiadeh SMJ, Safari H, Alizadesani M, Taghipour A, Dehghan A (2020). The Possible Role of Pathogenic and Non-Pathogenic Bacteria in Initiation and Exacerbation of Celiac Disease; a Comprehensive Review. Current Pharmaceutical Biotechnology, 21(6), 452-466. |
Chicago | Azimi T, Nasser A, Shariati A, Shiadeh SMJ, Safari H, Alizadesani M, Taghipour A, Dehghan A. "The Possible Role of Pathogenic and Non-Pathogenic Bacteria in Initiation and Exacerbation of Celiac Disease; a Comprehensive Review." Current Pharmaceutical Biotechnology 21, no. 6 (2020): 452-466. |
Harvard | Azimi T et al. (2020) 'The Possible Role of Pathogenic and Non-Pathogenic Bacteria in Initiation and Exacerbation of Celiac Disease; a Comprehensive Review', Current Pharmaceutical Biotechnology, 21(6), pp. 452-466. |
Vancouver | Azimi T, Nasser A, Shariati A, Shiadeh SMJ, Safari H, Alizadesani M, et al.. The Possible Role of Pathogenic and Non-Pathogenic Bacteria in Initiation and Exacerbation of Celiac Disease; a Comprehensive Review. Current Pharmaceutical Biotechnology. 2020;21(6):452-466. |
BibTex | @article{ author = {Azimi T and Nasser A and Shariati A and Shiadeh SMJ and Safari H and Alizadesani M and Taghipour A and Dehghan A}, title = {The Possible Role of Pathogenic and Non-Pathogenic Bacteria in Initiation and Exacerbation of Celiac Disease; a Comprehensive Review}, journal = {Current Pharmaceutical Biotechnology}, volume = {21}, number = {6}, pages = {452-466}, year = {2020} } |
RIS | TY - JOUR AU - Azimi T AU - Nasser A AU - Shariati A AU - Shiadeh SMJ AU - Safari H AU - Alizadesani M AU - Taghipour A AU - Dehghan A TI - The Possible Role of Pathogenic and Non-Pathogenic Bacteria in Initiation and Exacerbation of Celiac Disease; a Comprehensive Review JO - Current Pharmaceutical Biotechnology VL - 21 IS - 6 SP - 452 EP - 466 PY - 2020 ER - |